Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4341)
All Articles published online
|
Apr 7, 2011 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang ZM, Guo JX, Zhang ZC, Jiang N, Zhang ZY, Pan LJ. Therapeutic options for intermediate-advanced hepatocellular carcinoma. World J Gastroenterol 2011; 17(13): 1685-1689 [PMID: 21483627 DOI: 10.3748/wjg.v17.i13.1685] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i13/1685.htm |
| Number | Citing Articles |
| 1 |
Mohamed Houseni, Mahmoud Abdel Aziz Abdel Hady, Sameh Abokoura. Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma. Egyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00276-6
|
| 2 |
Muhammad Tarek Abdel Ghafar, Morad Ahmed Morad, Enas A. El-Zamarany, Dina Ziada, Hanan Soliman, Sherief Abd-Elsalam, Marwa Salama. Autologous dendritic cells pulsed with lysate from an allogeneic hepatic cancer cell line as a treatment for patients with advanced hepatocellular carcinoma: A pilot study. International Immunopharmacology 2020; 82: 106375 doi: 10.1016/j.intimp.2020.106375
|
| 3 |
Yong-Kang Diao, Lu Sun, Ming-Da Wang, Jun Han, Yong-Yi Zeng, Lan-Qing Yao, Xiao-Dong Sun, Chao Li, Guang-Zhao Shao, Li-Hui Gu, Han Wu, Jia-Hao Xu, Kong-Ying Lin, Zhong-Qi Fan, Wan Yee Lau, Timothy M. Pawlik, Feng Shen, Guo-Yue Lv, Tian Yang. Development and validation of nomograms to predict survival and recurrence after hepatectomy for intermediate/advanced (BCLC stage B/C) hepatocellular carcinoma. Surgery 2024; 176(1): 137 doi: 10.1016/j.surg.2024.03.028
|
| 4 |
Mattia Garancini, Enrico Pinotti, Stefano Nespoli, Fabrizio Romano, Luca Gianotti, Vittorio Giardini. Hepatic resection beyond barcelona clinic liver cancer indication: When and how. World Journal of Hepatology 2016; 8(11): 513-519 doi: 10.4254/wjh.v8.i11.513
|
| 5 |
Peng-Sheng Yi, Ming Zhang, Ji-Tong Zhao, Ming-Qing Xu. Liver resection for intermediate hepatocellular carcinoma. World Journal of Hepatology 2016; 8(14): 607-615 doi: 10.4254/wjh.v8.i14.607
|
| 6 |
Eric Stokes, Tian Shuang, Yanjie Zhang, Yanxi Pei, Ming Fu, Baoqing Guo, Amadeo Parissenti, Lingyun Wu, Rui Wang, Guangdong Yang. Efflux inhibition by H2S confers sensitivity to doxorubicin-induced cell death in liver cancer cells. Life Sciences 2018; 213: 116 doi: 10.1016/j.lfs.2018.10.031
|
| 7 |
T.J. Vogl, B. Panahi, S. Fischer, N. Naguib, N.-E.A. Nour-Eldin, T. Gruber, J. Trojan, W. Bechstein, S. Zangos, K. Eichler. Interventionelle Therapie von Lungen- und Lebermetastasen. Der Onkologe 2014; 20(8): 746 doi: 10.1007/s00761-014-2669-3
|
| 8 |
Felipe Nasser, Rafael N. Cavalcante, Francisco L. Galastri, Marcelo B. de Rezende, Guilherme G. Felga, Fabiellen B. Travassos, Bruna De Fina, Breno B. Affonso. Safety and Feasibility of Same-Day Discharge of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization with Drug-Eluting Beads in a Liver Transplantation Program. Journal of Vascular and Interventional Radiology 2014; 25(7): 1012 doi: 10.1016/j.jvir.2014.02.025
|
| 9 |
Yuxin Zhou, Na Lu, Haiwei Zhang, Libin Wei, Lei Tao, Qinsheng Dai, Li Zhao, Biqi Lin, Qilong Ding, Qinglong Guo. HQS-3, a newly synthesized flavonoid, possesses potent anti-tumor effect in vivo and in vitro. European Journal of Pharmaceutical Sciences 2013; 49(4): 649 doi: 10.1016/j.ejps.2013.04.016
|
| 10 |
Sanfeng Han, Tao Ye, Yuqin Mao, Bo Hu, Chen Wang, Tian jiao Wang. Cuproptosis-Related Genes CDK1 and COA6 Involved in the Prognosis Prediction of Liver Hepatocellular Carcinoma. Disease Markers 2023; 2023: 1 doi: 10.1155/2023/5552798
|
| 11 |
Gang Dong, Xia‑Hui Lin, Hua‑Hua Liu, Dong‑Mei Gao, Jie‑Feng Cui, Zheng‑Gang Ren, Rong‑Xin Chen. Intermittent hypoxia alleviates increased VEGF and pro‑angiogenic potential in liver cancer cells. Oncology Letters 2019; doi: 10.3892/ol.2019.10486
|
| 12 |
Y.-G. Wang, L. Li, C.-H. Liu, S. Hong, M.-J. Zhang. Peroxiredoxin 3 is resistant to oxidation-induced apoptosis of Hep-3b cells. Clinical and Translational Oncology 2014; 16(6): 561 doi: 10.1007/s12094-013-1117-y
|
| 13 |
Philippe Kolly, Helen Reeves, Bruno Sangro, Marina Knöpfli, Daniel Candinas, Jean‐François Dufour. Assessment of the Hong Kong Liver Cancer Staging System in Europe. Liver International 2016; 36(6): 911 doi: 10.1111/liv.13045
|
| 14 |
Koichiro Yamakado, Shozo Hirota. Sub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomas. World Journal of Gastroenterology 2015; 21(37): 10604-10608 doi: 10.3748/wjg.v21.i37.10604
|
| 15 |
Fan Cheung, Xuanbin Wang, Ning Wang, Man-Fung Yuen, Tat-chi Ziea, Yao Tong, Vivian Taam Wong, Yibin Feng. Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/487919
|
| 16 |
Jian-Hong Zhong, A. Chapin Rodríguez, Yang Ke, Yan-Yan Wang, Lin Wang, Le-Qun Li. Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular Invasion. Medicine 2015; 94(3): e396 doi: 10.1097/MD.0000000000000396
|
| 17 |
Giovan Giuseppe Di Costanzo, Raffaella Tortora. Intermediate hepatocellular carcinoma: How to choose the best treatment modality?. World Journal of Hepatology 2015; 7(9): 1184-1191 doi: 10.4254/wjh.v7.i9.1184
|
| 18 |
Gang Yuan, Yanneng Xu, Yunqiao Wang, Xun Zhang, Weiming Wang, Yanzheng He, Xiaoming Zhu. Development of a Hepatic VX2 carcinoma model in rabbits using an improved minimally invasive method and evaluation with imaging examinations. Journal of Cancer Research and Therapeutics 2022; 18(7): 1973 doi: 10.4103/jcrt.jcrt_1070_22
|
| 19 |
Asmaa I Gomaa, Imam Waked. Recent advances in multidisciplinary management of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(4): 673-687 doi: 10.4254/wjh.v7.i4.673
|
| 20 |
Duraikannu Arul, Perumal Subramanian. Naringenin (Citrus Flavonone) Induces Growth Inhibition, Cell Cycle Arrest and Apoptosis in Human Hepatocellular Carcinoma Cells. Pathology & Oncology Research 2013; 19(4): 763 doi: 10.1007/s12253-013-9641-1
|
| 21 |
Xiao Xu, Ming-Da Wang, Jia-Hao Xu, Zhong-Qi Fan, Yong-Kang Diao, Zhong Chen, Hang-Dong Jia, Fu-Bao Liu, Yong-Yi Zeng, Xian-Ming Wang, Han Wu, Wei Qiu, Chao Li, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Guo-Yue Lv, Tian Yang. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma a multicenter propensity matching analysis. Frontiers in Immunology 2024; 14 doi: 10.3389/fimmu.2023.1322233
|
| 22 |
Wei Liu, Jian-Guo Zhou, Yi Sun, Lei Zhang, Bao-Cai Xing. Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis. Journal of Gastrointestinal Surgery 2015; 19(7): 1271 doi: 10.1007/s11605-015-2811-6
|
| 23 |
Hyunsoo Kim, Su Jong Yu, Injun Yeo, Young Youn Cho, Dong Hyeon Lee, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Sungyoung Lee, Jongsoo Jun, Taesung Park, Jung-Hwan Yoon, Youngsoo Kim. Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS). Molecular & Cellular Proteomics 2017; 16(7): 1312 doi: 10.1074/mcp.M116.066704
|
| 24 |
Zhi-Bo Xie, Liang Ma, Xiao-Bo Wang, Tao Bai, Jia-Zhou Ye, Jian-Hong Zhong, Le-Qun Li. Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review. Tumor Biology 2014; 35(9): 8451 doi: 10.1007/s13277-014-2340-z
|
| 25 |
Maria Tampaki, Polyxeni P Doumba, Melanie Deutsch, John Koskinas. Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights. World Journal of Hepatology 2015; 7(14): 1834-1842 doi: 10.4254/wjh.v7.i14.1834
|
| 26 |
T.J. Vogl, F. Marquardt, W. Bechstein, J. Trojan, N.N.N. Naguib, T. Gruber-Rouh, M. Beeres, C. Lee. Interventionelle Therapie primärer Lebertumoren. Der Onkologe 2012; 18(7): 593 doi: 10.1007/s00761-012-2237-7
|
| 27 |
Samar S. Azab, Mohamed Abdel-Daim, Omayma A. Eldahshan. Phytochemical, cytotoxic, hepatoprotective and antioxidant properties of Delonix regia leaves extract. Medicinal Chemistry Research 2013; 22(9): 4269 doi: 10.1007/s00044-012-0420-4
|
| 28 |
Yuichi Sugino, Koichiro Yamakado, Takashi Yamanaka, Masashi Fujimori, Atsuhiro Nakatsuka, Haruyuki Takaki, Yoshiyuki Takei, Hajime Sakuma, Shuji Isaji. Role of curative treatment in patients with intermediate-stage hepatocellular carcinoma. Japanese Journal of Radiology 2017; 35(5): 254 doi: 10.1007/s11604-017-0628-9
|
| 29 |
J.-F. Dufour, I. Bargellini, N. De Maria, P. De Simone, I. Goulis, R.T. Marinho. Intermediate hepatocellular carcinoma: current treatments and future perspectives. Annals of Oncology 2013; 24: 24 doi: 10.1093/annonc/mdt054
|
| 30 |
LILI ZHANG, SU YU, ZHIJUN DUAN, QIUMING WANG, GE TIAN, YAN TIAN, WEI ZHAO, HUI WANG, CUILING ZHANG, SHIBIN GUO, QIGUI LIU, GAOHONG HE, TENGFEI BIAN, JIUYANG CHANG, XUE JIN, DONGSHENG CUI. Treatment of liver cancer in mice by the intratumoral injection of an octreotide-based temperature-sensitive gel. International Journal of Molecular Medicine 2014; 33(1): 117 doi: 10.3892/ijmm.2013.1542
|
| 31 |
Jianyuan Xu, Yue Shan, Chenxia Zhang, Zehua Hong, Yuanwang Qiu. Effect of Chinese Medicines combined with transarterial chemoembolization on primary hepatic carcinoma: A systematic review and meta-analysis. Medicine 2023; 102(26): e34165 doi: 10.1097/MD.0000000000034165
|
| 32 |
Ferdinand Knieling, Maximilian J Waldner, Ruediger S Goertz, Deike Strobel. Quantification of dynamic contrast-enhanced ultrasound in HCC: prediction of response to a new combination therapy of sorafenib and panobinostat in advanced hepatocellular carcinoma. BMJ Case Reports 2012; : bcr2012007576 doi: 10.1136/bcr-2012-007576
|